№ files_lp_4_process_2_75309
File format: docx
Character count: 4696
File size: 18 KB
Year:
2015
Region / Country:
China
Subject:
Ethics in vaccine development
Document Type:
Research report / Ethical review
Organization:
National Catholic Bioethics Center (NCER)
Authors:
Bo Ma et al.; NCER reviewers
Target Audience:
Vaccine researchers, bioethicists, regulatory authorities
Source Material:
Electively aborted fetal lung tissue
Related Vaccines:
MMR, Chickenpox, Hepatitis-A, Shingles, Rabies, Polio
Ethical Concerns:
Collusion in tissue acquisition, use of aborted fetal tissue, availability of alternative cell strains
Methodology:
Cell culture preparation, virus inoculation and propagation, virus harvest, purification
Comparative Analysis:
WI-38, MRC-5 cell strains
Regulatory Notes:
FDA approval of alternative cell strains for vaccines
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Contextual description:
Form used for depositing strains of algae and cyanobacteria into the KSA Algae Living Library, detailing information on isolation, cultivation conditions, and strain characteristics.
Year:
2024
Region / city:
Johannesburg
Theme:
Consumer credit, financial stress, inflation
Document type:
Report
Organization:
Experian
Author:
Jaco van Jaarsveldt
Target audience:
Financial institutions, consumers
Period of validity:
Q4 2023
Approval date:
12 March 2024
Date of changes:
None
Context:
A report on the financial strain faced by credit-active consumers in South Africa, particularly in relation to home loans, vehicle loans, and credit card defaults, influenced by high interest rates and inflation.
Year:
2021
Region / City:
Delta State, Nigeria
Subject:
Biosurfactants, Petroleum Bioremediation
Document Type:
Research Article
Organization / Institution:
Federal College of Education, Pankshin
Author:
Grace Avuwakoghene Okenmor, Justina Selman Ngap
Target Audience:
Researchers in environmental science, microbiology, bioremediation
Period of Validity:
N/A
Date of Approval:
N/A
Date of Changes:
N/A
Year:
2023
Region / city:
Not specified
Topic:
Injury recovery, running, calf strain
Document type:
Health advice
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Runners, athletes, individuals recovering from calf strain
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Context:
A guide to calf strain recovery and safe return to running, including tips for pain relief, fitness maintenance, and injury prevention.
Year:
2023
Region / City:
Not specified
Topic:
DNA-DNA Hybridization
Document type:
Supplementary Table
Author:
Not specified
Target audience:
Researchers in microbiology
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Context:
This table presents the DNA-DNA hybridization data from GGDC for various strains with strain AB800T as the query.
Year:
2026
Region / City:
United States, Washington D.C.
Subject:
Pesticide Registration and Data Submission Requirements
Document Type:
Official Notice / Regulatory Communication
Agency:
U.S. Environmental Protection Agency, Office of Pesticide Programs
Author:
U.S. Environmental Protection Agency
Target Audience:
Registrants of pesticide products containing Trichoderma harzianum Rifai strain T-22
Period of Effect:
90 days from receipt of notice
Date Issued:
2026
Legal Basis:
Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA); Federal Food, Drug, and Cosmetic Act (FFDCA); 40 CFR Part 155
Attachments:
Data Call-In Notice, Cover Letter, Attachments 1–5
Response Method:
Central Data Exchange (CDX) or postal submission
OMB Control Number:
2070-0174
Confidentiality:
Statement of Formula, Certification Documents, PRA Notification
Year:
2026
Institution:
Singapore Institute of Food and Biotechnology Innovation, A*STAR
Authors:
Pnelope Ng, Leng Wei Khoo, Aaron Thong, Wee Chew
Corresponding author:
Wee Chew, [email protected]
Field:
Metabolomics, Analytical Chemistry, Microbial Biotechnology
Document type:
Research article
Target organism:
Engineered Escherichia coli
Analytical technique:
LC-ToF-MS
Method focus:
Extraction optimization using statistical experimental design (DoE)
Validation standards:
Metabolomics Standards Initiative, ICH Q2 (R1)
Keywords:
Mevalonate pathway, LC-ToF-MS, Extraction, Design of experiment, Engineered E. coli
Publication date:
2026
Year:
2021
Region / City:
Kyiv, Ukraine
Field:
Medical Research
Document Type:
Clinical Study
Organization:
Bogomolets National Medical University, Taras Shevchenko National University of Kyiv
Authors:
Elina Manzhalii, Valentyna Moyseyenko, Vitalii Kondratiuk, Nataliia Molochek, Tetyana Falalyeyeva, Nazarii Kobyliak
Target Audience:
Medical professionals, researchers in gastroenterology and hepatology
Duration:
January 2017 - March 2020
Approval Date:
February 22, 2022
Date of Last Revision:
August 1, 2021
Year:
2025
Region / City:
United Kingdom
Subject:
Viral Hepatitis Management
Document Type:
Clinical Guideline
Author:
Lucy Garvey, Sanjay Bhagani, Ranjababu Kulasegaram, Michael Butler, Emma Hathorn, Paul Randal, Sarah Smith, Ryan White, Rachel Halford, Alison Grant, Giovanni Villa, Subathira Dakshina, Sema Mandal, Dan Bradshaw
Target Audience:
Healthcare professionals in sexual health and infectious diseases
Period of Validity:
2025
Approval Date:
July 21, 2025
Version:
1.2
Version Date:
July 21, 2025
Year:
2025
Region / City:
Massachusetts
Topic:
Healthcare Personnel, Respiratory Viral Infections
Document Type:
Guidance
Agency / Institution:
Commonwealth of Massachusetts, Executive Office of Health and Human Services, Department of Public Health
Author:
N/A
Target Audience:
Healthcare Personnel
Effective Date:
September 1, 2025
Date of Approval:
N/A
Date of Amendments:
May 3, 2024
Year:
2023
Region / city:
Not specified
Topic:
Hepatitis B, Hepatitis C, Public health
Document type:
Data collection form
Organization / institution:
Centers for Disease Control and Prevention (CDC)
Author:
Not specified
Target audience:
Healthcare professionals, Public health departments
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Contextual description:
A form used to gather clinical and diagnostic data from patients with recent hepatitis B or C infections, without known risk factors, to assess potential healthcare exposure windows for further public health investigation.
Year:
N/A
Region / city:
Worldwide
Topic:
Bovine viral diarrhoea (BVD)
Document type:
Scientific article
Author:
N/A
Target audience:
Veterinarians, researchers, agricultural professionals
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Contextual description:
A scientific article on the distribution, symptoms, diagnosis, and vaccination of bovine viral diarrhoea (BVD), including its impact on cattle health and veterinary management practices.
Year:
2021
Month:
August
Region:
England
Healthcare setting:
Primary care
Clinical area:
Paediatrics
Conditions covered:
Bronchiolitis; Viral induced wheeze; Viral lower respiratory tract infections
Document type:
Clinical guidance
Authors:
Clare Harris; Sanjay Patel; Zena Penny; David James; Sally Robins; Julia Shaw; Natalie Smith; Jo Borbone; Kathryn Bannell; Mark Alderton; Olie Morris; Sian Butterworth
Affiliated organisations:
Healthier Together; Hampshire CCGs; NHS England
Target audience:
Primary care clinicians
Patient population:
Infants and children
Referral pathways:
Primary to secondary care
Associated programmes:
Palivizumab programme
Guidance source:
Healthier Together clinical pathways
Year:
1918
Region / City:
Worldwide
Subject:
Influenza, Pandemic, Viral Theory
Document Type:
Article
Organization / Institution:
None specified
Author:
Unknown
Target Audience:
General Public, Medical Professionals
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
Not specified
Region / City:
Not specified
Theme:
Viral vectors for Parkinson’s disease research
Document Type:
Request Form
Organization / Institution:
University of Iowa, Viral Vector Core Facility
Author:
Not specified
Target Audience:
Researchers from non-profit and for-profit entities
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Note:
Year
Subject:
Gene Transfer, Targeting, and Therapeutics
Document Type:
Request Form
Organization / Institution:
Salk Institute
Target Audience:
Researchers and Lab personnel
Context:
A form for requesting viral vectors from the Gene Transfer, Targeting, and Therapeutics Facility at the Salk Institute for scientific research purposes.
Year:
2023
Programme:
Collaborative Training Partnership in Advanced Bioscience of Viral Products (ABViP CTP)
Funding body:
Biotechnology and Biological Sciences Research Council (BBSRC)
Affiliated framework:
UK Research and Innovation (UKRI)
Lead organisation:
Oxford Biomedica
Academic partners:
University College London; University of Oxford
Type of document:
Supervisor Project Application Form and Guidance Notes
Number of students:
24 over three years (eight per year)
Research focus:
Viral vectors for gene therapies and vaccines
Research themes:
Viral vector production and optimisation; Bioprocessing; Bioanalytics; Digitalisation and AI; Molecular pathways; Vector targeting and tropism; Immunological response
Supervision requirement:
Two academic supervisors with complementary expertise
Selection body:
ABViP CTP Management Board
Assessment criteria:
Scientific excellence; Research methodology; Project impact; Timeline; Risks; Cost and resources; Supervision arrangements
Contact persons:
Emily Kostas; David Hyland
Appendices:
List of proposed project topics; Training and development activities
Year:
2026
Region / City:
La Jolla, CA
Topic:
Gene Transfer, Viral Vectors
Document Type:
Request Form
Organization / Institution:
Salk Institute for Biological Studies
Author:
GT3 Core Facility
Target Audience:
Researchers, Investigators
Validity Period:
N/A
Approval Date:
N/A
Modification Date:
N/A
Note:
Year
Theme:
Outbreak management, gastroenteritis
Document Type:
Guidelines
Target Audience:
Environmental Health Officers
Context description:
A set of guidelines for Environmental Health Officers to assess and manage viral gastroenteritis outbreaks in specific facilities.
Facility:
Gene Transfer, Targeting and Therapeutics Facility
Institution:
Salk Institute for Biological Studies
Document Type:
Viral Vector Request Form
Subject:
Stock Reporter Viral Vectors
Submission Method:
Email to [email protected]
Required Information:
Principal Investigator, Lab Contact, Order Date, Fund Number or PO Number, Billing and Shipping Address
Aliquot Size AAV:
25 µl
Aliquot Size Lentiviral, Retroviral, Rabies:
5 µl
Vector Categories:
rAAV, Cre, DIO, FLEX, DO, Lentivirus, AAV Serotype Kits
Source References:
Addgene; Deisseroth Lab (Stanford University)
Material Transfer Requirement:
MTA required for Deisseroth Lab vectors
Titer Information:
Representative lot titers provided; actual titers may vary